Monday, November 16, 2009
The Associated Press on the new recommendations re screening mammograms
the US Preventive Task Force Changes Mammogram Recommendations!
The new recommendations reverse longstanding guidelines and are aimed at reducing harm from overtreatment, the group says. It also says women age 50 to 74 should have mammogramsless frequently — every two years, rather than every year. And it said doctors should stop teaching women to examine their breasts on a regular basis.
Just seven years ago, the same group, the United States Preventive Services Task Force, with different members, recommended that women have mammograms every one to two years starting at age 40. It found too little evidence to take a stand on breast self-examinations.
While many women do not think a screening test can be harmful, medical experts say the risks are real. They include unnecessary tests, like biopsies that can create extreme anxiety. And mammograms can find cancers that are better off not found. Some cancers grow so slowly that they never would be noticed in a woman’s lifetime. When they are found, women end up being treated unnecessarily.
This is huge! The US Preventative Task Force has a lot of impact on what screening tests get done and what doesn't. After nearly 30 years of recommending a test that does more harm than good, it's starting to look like there's going to be some recognition and improvement. This will result in an immediate drop in the number of women needlessly diagnosed with breast cancers that posed no risk to their health. It will cut the needless anxiety from a false alarm dramatically as well.
All you hospitals out there that budgeted to make more money on screening mammograms next year compared to this year, you might want to redo the budget.
Just sayin'
Thanksgiving
Drug Companies Price Gouging to Prepare for Health Care "Reform"
Friday, November 6, 2009
Kiva Hits 100 Million Today
Kiva Fast Facts
49
months old
$100,667,535
raised
98%
repayment rate
246,720
entrepreneurs funded
586,995
Kiva users
172
countries represented
Thursday, November 5, 2009
CDC Flu Charts
Interview with an influenza Guru
SPIEGEL: For a number of years, as part of the Cochrane Collaboration, you have been systematically evaluating all the studies on immunization against seasonal influenza. How good does it work?
Jefferson: Not particularly good. An influenza vaccine is not working for the majority of influenza-like illnesses because it is only designed to combat influenza viruses. For that reason, the vaccine changes nothing when it comes to the heightened mortality rate during the winter months. And, even in the best of cases, the vaccine only works against influenza viruses to a limited degree. Among other things, there is always the danger that the flu virus in circulation will have changed by the time that the vaccine product is finished with the result that, in the worst case, the vaccine will be totally ineffectual. In the best of cases, the few decent studies that exist show that the vaccine mainly works with healthy young adults. With children and the elderly, it only helps a little, if at all.
SPIEGEL: But aren't those the exact groups that influenza immunization is recommended for?
Jefferson: Indeed. That's one of the contradictions between scientific findings and practice, between evidence and policy.
SPIEGEL: So, what's behind this contradiction?
Jefferson: Of course, that has something to do with the influence of the pharmaceutical industry. But it also has to do with the fact that the importance of influenza is completely overestimated. It has to do with research funds, power, influence and scientific reputations!